Localization of MAP1-LC3 in vulnerable neurons and lewy bodies in brains of patients with dementia with lewy bodies

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 4, 2011, Pages 264-280

  Higashi, Shinji ^a,b,c,d   Moore, Darren J ^e   Minegishi, Michiko ^a   Kasanuki, Koji ^a,c,f   Fujishiro, Hiroshige ^a,f   Kabuta, Tomohiro ^b   Togo, Takashi ^g   Katsuse, Omi ^g   Uchikado, Hirotake ^g   Furukawa, Yoshiko ^g   Hino, Hiroaki ^c   Kosaka, Kenji ^a,c,f   Sato, Kiyoshi ^a   Arai, Heii ^f   Wada, Keiji ^b   Iseki, Eizo ^a,f  

^a JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c Yokohama Houyuu Hospital   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e EPFL   (Switzerland)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Synuclein; Autophagy; Dementia with Lewy bodies; Endosome; LC3; Lysosome

Indexed keywords

BRAIN PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 1A 1B LIGHT CHAIN 3; RAS RELATED PROTEIN RAB 7B; UNCLASSIFIED DRUG;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; AUTOPHAGY; BIOACCUMULATION; BRAIN NERVE CELL; BRAIN STEM; BRAIN TISSUE; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFUSE LEWY BODY DISEASE; ENDOSOME; ENTORHINAL CORTEX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIMBIC CORTEX; MALE; NEOCORTEX; NEUROCHEMISTRY; NEUROPATHOLOGY; PHAGOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AUTOPHAGY; BLOTTING, WESTERN; BRAIN; CELL COUNT; ENTORHINAL CORTEX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LEWY BODY DISEASE; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; PLASMIDS; RAB GTP-BINDING PROTEINS;

EID: 79953167820     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318211c86a     Document Type: Article

References (69)

1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005;65:1863-72 (Pubitemid 43970103)
2. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18:106-8
3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47 (Pubitemid 27443610)
4. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841 (Pubitemid 37339619)
5. Spira PJ, Sharpe DM, Halliday G, et al. Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 2001;49:313-19 (Pubitemid 32202784)
6. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73 (Pubitemid 38166992)
7. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-79 (Pubitemid 38166993)
8. Obi T, Nishioka K, Ross OA, et al. Clinicopathologic study of an SNCA gene duplication patient with Parkinson disease and dementia. Neurology 2008;70:238-41
9. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-40
10. Sandal M, Valle F, Tessari I, et al. Conformational equilibria in mono-meric alpha-synuclein at the single-molecule level. PLoS Biol 2008;6:e6
11. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998;4:1318-20 (Pubitemid 28512115)
12. Conway KA, Lee SJ, Rochet JC, et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci USA 2000;97:571-76 (Pubitemid 30070350)
13. Narhi L, Wood SJ, Steavenson S, et al. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 1999;274: 9843-46
14. Olanow CW, McNaught KS. Ubiquitin-proteasome system and Parkinson's disease. Mov Disord 2006;21:1806-23 (Pubitemid 44856478)
15. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8 (Pubitemid 28207717)
16. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-52
17. Kirkin V, McEwan DG, Novak I, et al. A role for ubiquitin in selective autophagy. Mol Cell 2009;34:259-69
18. Komatsu M, Waguri S, Koike M, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007;131:1149-63 (Pubitemid 350235021)
19. Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282:24131-45 (Pubitemid 47328003)
20. Kuusisto E, Salminen A, Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synu-cleinopathies. Neuroreport 2001;12:2085-90 (Pubitemid 32646250)
21. Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-89
22. Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006;441: 880-84
23. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997;12:25-31 (Pubitemid 27106916)
24. Cuervo AM, Stefanis L, Fredenburg R, et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292-95 (Pubitemid 39129234)
25. Lee HJ, Khoshaghideh F, Patel S, et al. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004;24:1888-96 (Pubitemid 38292800)
26. Webb JL, Ravikumar B, Atkins J, et al. Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003;278:25009-13 (Pubitemid 37548663)
27. Plowey ED, Cherra SJ 3rd, Liu YJ, et al. Role of autophagy in G2019S-LRRK2Yassociated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 2008;105:1048-56 (Pubitemid 351565713)
28. MacLeod D, Dowman J, Hammond R, et al. The familial parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52:587-93 (Pubitemid 44781171)
29. Ramirez A, Heimbach A, Grundemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38:1184-91 (Pubitemid 44470365)
30. Gutierrez MG, Munafo DB, Beron W, et al. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J Cell Sci 2004;117:2687-97 (Pubitemid 38997252)
31. Jager S, Bucci C, Tanida I, et al. Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 2004;117:4837-48 (Pubitemid 39433449)
32. Liang C, Lee JS, Inn KS, et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 2008;10:776-87 (Pubitemid 351927707)
33. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immuno-cytochemistry. Acta Neuropathol 2006;112:389-404 (Pubitemid 44469160)
34. Marui W, Iseki E, Nakai T, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002;195:153-59 (Pubitemid 34202293)
35. Marui W, Iseki E, Kato M, et al. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Acta Neuropathol 2004;108:121-28 (Pubitemid 39136297)
36. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18:S1-2
37. Saito Y, Kawashima A, Ruberu NN, et al. Accumulation of phosphory-lated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003;62:644-54 (Pubitemid 36682637)
38. Kabuta T, Furuta A, Aoki S, et al. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 2008;283:23731-38
39. Higashi S, Iseki E, Minegishi M, et al. GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation. J Neurochem 2010;115:423-37
40. Higashi S, Iseki E, Yamamoto R, et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007;1184:284-94 (Pubitemid 350160566)
41. Dwass M. Some k-sample rank-order tests. In: Olkin I, Ghurye SG, Hoeffding H, Madow WG, Mann HB, eds. Contributions to Probability and Statistics. Palo Alto, CA: Stanford University Press, 1960
42. Steel RGD. A rank sum test for comparing all pairs of treatments. Technometrics 1960;2:197-207
43. Braak H, Tredici KD, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211 (Pubitemid 36007810)
44. Barrachina M, Maes T, Buesa C, et al. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. Neuropathol Appl Neurobiol 2006;32:505-16 (Pubitemid 44401512)
45. Fujiwara H, Hasegawa M, Dohmae N, et al. Alpha-synuclein is phos-phorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-64
46. Mizushima N, Yamamoto A, Matsui M, et al. In vivo analysis of au-tophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004;15: 1101-11 (Pubitemid 38316219)
47. Takahashi H, Wakabayashi K. The cellular pathology of Parkinson's disease. Neuropathology 2001;21:315-22 (Pubitemid 34130639)
48. Forno LS, Norville RL. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol 1976;34:183-97
49. Watanabe I, Vachal E, Tomita T. Dense core vesicles around the Lewy body in incidental Parkinson's disease: An electron microscopic study. Acta Neuropathol 1977;39:173-75 (Pubitemid 8153210)
50. Gitler AD, Bevis BJ, Shorter J, et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 2008;105:145-50
51. Higashi S, Moore DJ, Yamamoto R, et al. Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in Lewy body disease. J Neuropathol Exp Neurol 2009;68:994-1005
52. Schlossmacher MG, Frosch MP, Gai WP, et al. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 2002;160:1655-67 (Pubitemid 34525646)
53. Wakabayashi K, Engelender S, Tanaka Y, et al. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neu-rodegenerative disorders. Acta Neuropathol 2002;103:209-14 (Pubitemid 36075320)
54. Shin N, Jeong H, Kwon J, et al. LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 2008;314:2055-65
55. Fallon L, Belanger CM, Corera AT, et al. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 2006;8:834-42 (Pubitemid 44151586)
56. Alegre-Abarrategui J, Christian H, Lufino MM, et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 2009;18: 4022-34
57. Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008; 183:795-803
58. Xiong Y, Coombes CE, Kilaru A, et al. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet 2010;6:e1000902
59. Vogiatzi T, Xilouri M, Vekrellis K, et al. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008;283:23542-56
60. Crews L, Spencer B, Desplats P, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 2010;5:9313
61. Dehay B, Bove J, Rodriguez-Muela N, et al. Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci 2010;30:12535-44
62. Baehrecke EH. Autophagy: Dual roles in life and death? Nat Rev Mol Cell Biol 2005;6:505-10 (Pubitemid 40780562)
63. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006;443:796-802 (Pubitemid 44622684)
64. Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of au-tophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol 2005;64:113-22 (Pubitemid 40349309)
65. Pan T, Kondo S, Le W, et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008;131: 1969-78
66. Cooper AA, Gitler AD, Cashikar A, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006;313:324-28 (Pubitemid 44480951)
67. Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 2007;120:4081-91
68. Ma JF, Huang Y, Chen SD, et al. Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease. Neuropathol Appl Neurobiol 2010;36:312-19
69. Hatano T, Kubo SI, Sato S, et al. Pathogenesis of familial Parkinson's disease: New insights based on monogenic forms of Parkinson's disease. J Neurochem 2009;111:1075-93